, a bio/informatics shared resource is still "open for business" - Visit the CDS website

  1. Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells. Miura A, Yamagata K, Kakei M, Hatakeyama H, Takahashi N, Fukui K, Nammo T, Yoneda K, Inoue Y, Sladek FM, Magnuson MA, Kasai H, Miyagawa J, Gonzalez FJ, Shimomura I (2006) J Biol Chem 281(8): 5246-57
    › Primary publication · 16377800 (PubMed)
  2. Cholinergic regulation of fuel-induced hormone secretion and respiration of SUR1-/- mouse islets. Doliba NM, Qin W, Vatamaniuk MZ, Buettger CW, Collins HW, Magnuson MA, Kaestner KH, Wilson DF, Carr RD, Matschinsky FM (2006) Am J Physiol Endocrinol Metab 291(3): E525-35
    › Primary publication · 16638820 (PubMed)
  3. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, Magnuson MA, Redha R, Zhang Y, Breyer MD (2005) Nat Med 11(8): 861-6
    › Primary publication · 16007095 (PubMed)
  4. Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass. Roccisana J, Reddy V, Vasavada RC, Gonzalez-Pertusa JA, Magnuson MA, Garcia-Ocaña A (2005) Diabetes 54(7): 2090-102
    › Primary publication · 15983210 (PubMed)
  5. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Thierbach R, Schulz TJ, Isken F, Voigt A, Mietzner B, Drewes G, von Kleist-Retzow JC, Wiesner RJ, Magnuson MA, Puccio H, Pfeiffer AF, Steinberg P, Ristow M (2005) Hum Mol Genet 14(24): 3857-64
    › Primary publication · 16278235 (PubMed)
  6. Strategies for the use of site-specific recombinases in genome engineering. Jones JR, Shelton KD, Magnuson MA (2005) Methods Mol Med : 245-57
    › Primary publication · 15542911 (PubMed)
  7. Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene. Park SY, Wang X, Chen Z, Powers AC, Magnuson MA, Head WS, Piston DW, Bell GI (2005) Genesis 43(2): 80-6
    › Primary publication · 16108006 (PubMed)
  8. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. Gloyn AL, Odili S, Zelent D, Buettger C, Castleden HA, Steele AM, Stride A, Shiota C, Magnuson MA, Lorini R, d'Annunzio G, Stanley CA, Kwagh J, van Schaftingen E, Veiga-da-Cunha M, Barbetti F, Dunten P, Han Y, Grimsby J, Taub R, Ellard S, Hattersley AT, Matschinsky FM (2005) J Biol Chem 280(14): 14105-13
    › Primary publication · 15677479 (PubMed)
  9. Impaired glucagon secretory responses in mice lacking the type 1 sulfonylurea receptor. Shiota C, Rocheleau JV, Shiota M, Piston DW, Magnuson MA (2005) Am J Physiol Endocrinol Metab 289(4): E570-7
    › Primary publication · 15941784 (PubMed)
  10. Imaging Beta cell development in real-time using pancreatic explants from mice with green fluorescent protein-labeled pancreatic Beta cells. Gunawardana SC, Hara M, Bell GI, Head WS, Magnuson MA, Piston DW (2005) In Vitro Cell Dev Biol Anim 41(1-2): 7-11
    › Primary publication · 15926862 (PubMed)